Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7LH5

Crystal structure of the Thermus thermophilus 70S ribosome in complex with plazomicin, mRNA and tRNAs

This is a non-PDB format compatible entry.
Summary for 7LH5
Entry DOI10.2210/pdb7lh5/pdb
Descriptor16S ribosomal RNA, 30S ribosomal protein S10, 30S ribosomal protein S11, ... (62 entities in total)
Functional Keywords70s ribosome, plazomicin, antibiotic resistance, aminoglycoside, ribosome
Biological sourceEscherichia coli
More
Total number of polymer chains118
Total formula weight4589368.96
Authors
Golkar, T.,Berghuis, A.M.,Schmeing, T.M. (deposition date: 2021-01-21, release date: 2021-06-02, Last modification date: 2024-10-30)
Primary citationGolkar, T.,Bassenden, A.V.,Maiti, K.,Arya, D.P.,Schmeing, T.M.,Berghuis, A.M.
Structural basis for plazomicin antibiotic action and resistance.
Commun Biol, 4:729-729, 2021
Cited by
PubMed Abstract: The approval of plazomicin broadened the clinical library of aminoglycosides available for use against emerging bacterial pathogens. Contrarily to other aminoglycosides, resistance to plazomicin is limited; still, instances of resistance have been reported in clinical settings. Here, we present structural insights into the mechanism of plazomicin action and the mechanisms of clinical resistance. The structural data reveal that plazomicin exclusively binds to the 16S ribosomal A site, where it likely interferes with the fidelity of mRNA translation. The unique extensions to the core aminoglycoside scaffold incorporated into the structure of plazomicin do not interfere with ribosome binding, which is analogously seen in the binding of this antibiotic to the AAC(2')-Ia resistance enzyme. The data provides a structural rationale for resistance conferred by drug acetylation and ribosome methylation, i.e., the two mechanisms of resistance observed clinically. Finally, the crystal structures of plazomicin in complex with both its target and the clinically relevant resistance factor provide a roadmap for next-generation drug development that aims to ameliorate the impact of antibiotic resistance.
PubMed: 34117352
DOI: 10.1038/s42003-021-02261-4
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (3.27 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon